Biovie (BIVI) Assets (2013 - 2026)
Biovie (BIVI) reported Assets of $14.25 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 33.9% from $21.56 million a year earlier and down 18.6% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Assets (2013 - 2026) Analysis & Trends
Dating back to fiscal Q4 2013, Biovie's Assets record includes 50 quarters.
- Assets has declined for three consecutive fiscal years, though with a five-year compound annual growth rate of 18.7% (FY2021 to FY2026).
- By fiscal year, Assets came in at $21.56 million in FY2025 (-14.5%), $25.21 million in FY2024 (-28.2%), $35.1 million in FY2023 (+74.5%) and $20.11 million in FY2022 (+232.7%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Assets since fiscal Q4 2021.
- Year over year, Assets has now declined in each of the last three quarters, with an average decline of 9.6% over the last eight quarters.
- The high point for year-over-year Assets in five years was fiscal Q4 2022 (growth of 232.7%); the low point was fiscal Q2 2024 (a decline of 54.5%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $17.51 million (Q3 2026), $22.5 million (Q2 2026) and $26.82 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Biovie | 11.62 Mn | 11.62 Mn | - | 14.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.25 Mn |
| Mar 31, 2026 | 17.51 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 26.82 Mn |
| Jun 30, 2025 | 21.56 Mn |
| Mar 31, 2025 | 24.66 Mn |
| Dec 31, 2024 | 25.69 Mn |
| Sep 30, 2024 | 21.24 Mn |
| Jun 30, 2024 | 25.21 Mn |
| Mar 31, 2024 | 31.77 Mn |
| Dec 31, 2023 | 21.49 Mn |
| Sep 30, 2023 | 23.76 Mn |
| Jun 30, 2023 | 35.10 Mn |
| Mar 31, 2023 | 45.18 Mn |
| Dec 31, 2022 | 47.19 Mn |
| Sep 30, 2022 | 22.86 Mn |
| Jun 30, 2022 | 20.11 Mn |
| Mar 31, 2022 | 26.19 Mn |
| Dec 31, 2021 | 31.87 Mn |
| Sep 30, 2021 | 21.98 Mn |
API Access
Biovie Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();